Uni-Bio Science Group Limited — Capital/Financing Update 2016

Oct 11, 2016

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [28 x 32] intentionally omitted <==

==> picture [21 x 25] intentionally omitted <==

==> picture [24 x 28] intentionally omitted <==

==> picture [291 x 45] intentionally omitted <==

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 0690)

CLARIFICATION ANNOUNCEMENT TO GRANT OF SHARE OPTIONS

Reference is made to the announcement (“ Announcement ”) of Uni-Bio Science Group Limited (“ Company ”) dated 7 October 2016 in relation to the grant of share options of the Company.

As set out in the Announcement, it was stated that the average closing price of the Shares for the five business days immediately preceding the date of grant was “HK$0.171 per Share”.

The Company wishes to clarify that, due to an inadvertent clerical error, the above quoted average closing price of the Shares for the five business days immediately preceding the date of grant should be read as “HK$0.1714 per Share” (emphasis added). Save as disclosed in this announcement, the contents of the Announcement remain unchanged.

By order of the Board Uni-Bio Science Group Limited TONG Kit Shing Chairman

Hong Kong, 11 October 2016

As at the date of this announcement, the Board comprises two executive Directors, namely, Mr. Tong Kit Shing (Chairman) and Mr. Kingsley Leung; and three independent non-executive Directors, namely, Dr. Carl Aslan Jason Morton Firth, Mr. Zhao Zhi Gang and Mr. Chow Kai Ming.

• For identification purpose only